CVE-2024-41668 cBioPortal Proxy Endpoint Vulnerabliity
HighCVSS 8.3
EPSS 0.58%
- Published
- Updated
- Exploit status
- No public exploit known
- CISA SSVC
- Proof of concept public · automatable: yes · technical impact: partial
- Technology
- Nginx
Description
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable /proxy endpoint entirely via, for example, nginx.
Upgrade path
2 packages: 1 fixed.
| Package | Affected | Fixed in | Status |
|---|---|---|---|
| cbioportal project cbioportal | < 6.0.12 | 6.0.12 | Fixed |
| cbioportal | = < 6.0.12 | No fix listed | Versions listed |
Affected products
| Product | Affected versions | Fixed in |
|---|---|---|
| cbioportal | = < 6.0.12 | No fix listed |
| cbioportal project cbioportal | < 6.0.12 | 6.0.12 |
References
- https://github.com/cBioPortal/cbioportal/security/advisories/GHSA-9h44-r3c3-q7rm
- https://github.com/cBioPortal/cbioportal/pull/10884
- https://github.com/cBioPortal/cbioportal/commit/ea8642fdbda2d61d2ab34b9da7a1594680bbbcd5
- https://github.com/cBioPortal/cbioportal/releases/tag/v6.0.12
- https://www.wizlynxgroup.com/security-research-advisories/vuln/WLX-2024-004